Jennifer Humes is a seasoned finance executive with over 20 years of experience in accounting and financial management, currently serving as the Chief Accounting Officer at Roivant Sciences Ltd., a biopharmaceutical company focused on innovative therapies for unmet medical needs. In this pivotal role, she oversees the company's global accounting operations, financial reporting, internal controls, and compliance with regulatory standards. Humes joined Roivant in 2018, bringing her expertise in navigating complex financial landscapes within the life sciences sector. Her leadership has been instrumental in streamlining accounting processes and ensuring accurate financial disclosures, which are critical for a publicly traded company like Roivant. Prior to Roivant, Humes held senior positions at several prominent organizations, including a decade-long tenure at Pfizer Inc., where she advanced from Senior Director of Finance to Vice President of Global Accounting. At Pfizer, she led the integration of financial systems following major acquisitions, resulting in significant cost savings and improved efficiency. Humes began her career at Deloitte, where she honed her skills in audit and advisory services, earning her CPA certification early on. She holds a Bachelor's degree in Accounting from the University of Pennsylvania's Wharton School and an MBA from Harvard Business School. Among her notable achievements, Humes has been recognized with the Women in Finance Award for her contributions to diversity in leadership roles and has published articles on ethical financial practices in industry journals. At Roivant Sciences, Humes plays a key role in supporting the company's mission to accelerate drug development through its unique "Vant" model. She has spearheaded initiatives to enhance financial transparency and risk management, particularly during periods of rapid growth and strategic partnerships. Her strategic insights have helped Roivant maintain robust financial health amid the challenges of the biotech industry, including market volatility and regulatory changes. Outside of her professional duties, Humes is an advocate for STEM education, serving on the board of a nonprofit that promotes financial literacy among underrepresented youth.